You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百心安-B(02185.HK)公佈業績,2022年度研發開支約1.58億元
格隆匯 03-31 23:31

格隆匯3月31日丨百心安-B(02185.HK)發佈公吿,截至2022年12月31日止年度,集團虧損淨額約為人民幣2.309億元,較2021年約人民幣4.098億元減少43.7%。2022年度的研發開支約為人民幣1.578億元,較2021年錄得的約人民幣2.142億元減少26.3%。截至2022年12月31日,現金及現金等價物約為人民幣4.513億元,較截至2021年12月31日的人民幣7.085億元減少36.3%。截至2022年12月31日,淨資產負債比率為6.8%(2021年:7.2%)。

集團的BRS及RDN產品分別於2022年2月及1月完成患者入組,目前均已完成臨牀隨訪。於2022年8月16日,集團宣佈Bioheart®BRS的隨機對照臨牀試驗已達到主要臨牀終點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account